Heidelberg Pharma AG (FRA:HPHA)
4.400
+0.260 (6.28%)
Aug 13, 2025, 4:00 PM EDT
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 105 employees as of November 30, 2024. The number of employees increased by 10 or 10.53% compared to the previous year.
Employees
105
Change (1Y)
10
Growth (1Y)
10.53%
Revenue / Employee
€37,687
Profits / Employee
€209,980
Market Cap
199.47M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 105 | 10 | 10.53% |
Nov 30, 2023 | 95 | -7 | -6.86% |
Nov 30, 2022 | 102 | 13 | 14.61% |
Nov 30, 2021 | 89 | 11 | 14.10% |
Nov 30, 2020 | 78 | 8 | 11.43% |
Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Siemens Energy AG | 98,000 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |
Heidelberg Pharma AG News
- 16 days ago - EQS-NVR: Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 23 days ago - EQS-DD: Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for ... - Wallstreet:Online
- 5 weeks ago - EQS-News: Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business - Wallstreet:Online
- 3 months ago - EQS-News: Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board - Wallstreet:Online
- 3 months ago - EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 - Wallstreet:Online
- 4 months ago - EQS-News: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025 - Wallstreet:Online
- 5 months ago - EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 - Wallstreet:Online